ENTG Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Entegris Inc (ENTG) is not a strong buy at the moment for a beginner investor with a long-term strategy. Despite positive analyst ratings and optimistic guidance for Q1 2026, the recent financial performance shows significant YoY declines in revenue, net income, and EPS. Additionally, insider selling has surged, and options data indicates bearish sentiment with a high put-call volume ratio. The technical indicators are mixed, with bullish moving averages but a neutral RSI and MACD contraction. Given the investor's impatience and unwillingness to wait for optimal entry points, holding off on buying ENTG is recommended until clearer signs of sustained growth and improved sentiment emerge.
The stock shows bullish moving averages (SMA_5 > SMA_20 > SMA_200), but RSI is neutral at 63.35, and MACD is positively contracting at 0.86. Key support is at 111.588, and resistance is at 134.837. The stock has a 60% chance of a slight decline (-1.31%) in the next day and a minor gain (0.28%) in the next week, indicating a lack of strong upward momentum.
Analysts have raised price targets significantly, with many maintaining Buy or Outperform ratings. The company exceeded Q4 2025 expectations and provided optimistic guidance for Q1 2026, citing demand for complex device architectures. Technical indicators show bullish moving averages.
Insider selling has surged by 1015.54% over the last month. Financial performance in Q4 2025 showed significant YoY declines in revenue (-3.05%), net income (-51.68%), and EPS (-52.24%). Options data indicates bearish sentiment, and the stock has declined significantly in regular and post-market trading (-5.00% and -3.74%, respectively).
In Q4 2025, revenue dropped to $823.9 million (-3.05% YoY), net income dropped to $49.4 million (-51.68% YoY), and EPS dropped to $0.32 (-52.24% YoY). Gross margin also declined to 38.15% (-4.93% YoY). Despite these declines, the company exceeded Q4 expectations and provided optimistic guidance for Q1 2026.
Analysts are generally positive, with multiple firms raising price targets (e.g., Citi to $155, BMO to $148, Mizuho to $150) and maintaining Buy or Outperform ratings. However, Deutsche Bank downgraded the stock to Hold, citing crosscurrents after a 35% YTD rise. Goldman Sachs maintains a Sell rating, awaiting clearer signs of a cyclical upturn and improved execution.
